LOGIN JOIN SHARECAFE SIGN UP FOR OUR NEWSLETTER ADVERTISE
share cafe logo  
 
SEARCH RESULT

CIRCADIAN TECHNOLOGIES LIMITED ( CIR )

Discuss CIR In The ShareScene Community


CLICK HERE TO TALK WITH OTHER INVESTORS ABOUT CIR +

CIR Commentary, Multimedia & ASX Announcements


Circadian Getting Into Its Rhythm11/11/2015 6:09:22 PM

There Is No Multimedia Available For This Company.

Circadian Technologies Changes Name to Opthea 12/11/2015 9:33:00 AM
Initial Director''s Interest Notice - MS 12/4/2015 4:35:00 PM
Initial Director''s Interest Notice - GK 12/4/2015 4:33:00 PM
Final Director''s Interest Notice - TM 12/4/2015 4:29:00 PM
Final Director''s Interest Notice - RH 12/4/2015 4:28:00 PM
Final Director''s Interest Notice - DF 12/4/2015 4:26:00 PM
Circadian Receives $3M R&D Tax Incentive 12/2/2015 9:25:00 AM
Circadian Board Changes and Renewal 11/30/2015 6:36:00 PM
Results of the Annual General Meeting 11/30/2015 6:18:00 PM
CEO Presentation for the Annual General Meeting 11/30/2015 6:18:00 PM
Chairman''s address to the Annual General Meeting 11/30/2015 6:16:00 PM
Trading Halt 11/30/2015 9:49:00 AM
Circadian/Opthea presentation at OIS 2015 11/13/2015 8:27:00 AM
Circadian to Present at US Ophthalmology Innovation Summit 11/10/2015 9:42:00 AM
Notice of Annual General Meeting and Proxy Form 10/30/2015 9:05:00 AM
Circadian to regain VEGFR-3 intellectual property license 10/23/2015 9:13:00 AM
Appendix 4G 9/30/2015 5:54:00 PM
Change in substantial holding 9/7/2015 2:01:00 PM
Appendix 4E and Annual Financial Report 2015 8/19/2015 9:43:00 AM
Circadian Corporate Presentation - July 2015 7/9/2015 9:53:00 AM
Change of Director''s Interest Notice - DF 7/2/2015 5:15:00 PM
Change of Director''s Interest Notice - MB 7/2/2015 5:12:00 PM
Appendix 3B 7/2/2015 5:09:00 PM
Circadian Commences Wet AMD OPT-302 Clinical Trial 7/1/2015 8:54:00 AM
Change in substantial holding 6/25/2015 10:06:00 AM
Circadian receives IND approval from FDA for Wet AMD Phase 1 6/15/2015 8:26:00 AM
Circadian partner Eli Lilly presents IMC-3C5 Ph1 at ASCO 6/2/2015 9:48:00 AM
OPT-302 Data Presented at Major Ophthalmology Conferences 5/7/2015 9:24:00 AM
Circadian Shareholder Newsletter April 2015 4/16/2015 12:30:00 PM
Half Year Report and Accounts 2/26/2015 5:48:00 PM
US Patent Granted for Soluble VEGFR-3 Traps 1/28/2015 9:17:00 AM
Circadian Receives $2.2M R&D Tax Incentive 1/23/2015 9:20:00 AM
Appendix 3B 1/15/2015 12:14:00 PM
Change of Director''s Interest Notice - DF 12/23/2014 2:07:00 PM
Change of Director''s Interest Notice - MB 12/23/2014 2:04:00 PM
Appendix 3B 12/23/2014 2:01:00 PM
Circadian Announces Formation of Clinical Advisory Board 12/3/2014 8:35:00 AM
Ceasing to be a substantial holder 11/27/2014 4:17:00 PM
Placement Cleansing Notice 11/27/2014 4:04:00 PM
Becoming a substantial holder 11/26/2014 11:17:00 AM
Completion of Placement and Appendix 3B 11/25/2014 5:28:00 PM
Change in substantial holding 11/25/2014 1:44:00 PM
Becoming a substantial holder 11/25/2014 12:47:00 PM
Change of Director''s Interest Notice 11/20/2014 4:32:00 PM
Change of Director''s Interest Notice 11/20/2014 4:30:00 PM

 

RECENTLY ADDED TO SHARECAFE


 › Synlait Milk Energised For Growth
 › Exchanged Traded Managed Funds, Tell Me More
 › Speeding Through Speedcast
 › Will New iPhones Solve Apple's China Problem?
 › Outlook Dims For TPG Telecom
 › Overnight: Magical Mystery Tour
 › Forget Bitcoin...Buy Commodities Instead
 › The Two Biggest Events Driving World Markets
 › SVW - Deutsche Bank rates the stock as Hold
 › GMA - Macquarie rates the stock as Outperform
 › NHF - Morgans rates the stock as Hold
 › Fed Ready To Unwind, Shrugs Off Inflation 'Mystery'
 › Coates Deal Forces Seven Into Equity Raising
 › Seven Group Buys Out Coates Hire
More ShareCafe   

GET THE SHARECAFE BREAKFAST BRIEFING


Delivered free to your inbox before the market opens each trading day. Sign up below +

SHARECAFE VIDEO


View More Videos